What is ANI Pharmaceuticals's debt repayments?

ANI Pharmaceuticals (ANIP) reported debt repayments of $4.06M in Q1 2026.

How has ANI Pharmaceuticals's debt repayments changed year-over-year?

ANI Pharmaceuticals's debt repayments increased by 100.0% year-over-year, from $2.03M to $4.06M.

What is the long-term trend for ANI Pharmaceuticals's debt repayments?

Over 4 years (2021 to 2025), ANI Pharmaceuticals's debt repayments has grown at a -100.0% compound annual growth rate (CAGR), from $200.15M to $0.

What does debt repayments mean?

Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.

ANI Pharmaceuticals ANIP Debt Repayments

Debt Repayments at other companies

Opko HealthOPK

$8.88M-7.0%

OrganonOGN

$32M-65.6%

LQD

Liquidia CorporationLQDA

$19.97M+841%

United TherapeuticsUTHR

$0-100%

Cardinal HealthCAH

$113M+927%

AmgenAMGN

$833M-66.7%

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.88B+18.3%

Enterprise value$1.87B+5.8%

P/E20.4×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfOtherLongTermDebt.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's debt repayments?: ANI Pharmaceuticals (ANIP) reported debt repayments of $4.06M in Q1 2026.
How has ANI Pharmaceuticals's debt repayments changed year-over-year?: ANI Pharmaceuticals's debt repayments increased by 100.0% year-over-year, from $2.03M to $4.06M.
What is the long-term trend for ANI Pharmaceuticals's debt repayments?: Over 4 years (2021 to 2025), ANI Pharmaceuticals's debt repayments has grown at a -100.0% compound annual growth rate (CAGR), from $200.15M to $0.
What does debt repayments mean?: Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.